Event Details
Ocular Treatments: A Cutting-Edge Approach
Sunday, March 9 | 11:00 AM – 5:30 PM ET | Zoom Webinar
Registration Options
• Please Note: Registration will end at 11:59 PM Pacific Time on Saturday, March 8.
• If you need assistance when registering, contact our Director of Member Education at 971.362.2866 or education@pecaa.com.
Event Summary
PECAA is pleased to announce its next COPE virtual education event: Ocular Treatments: A Cutting-Edge Approach. Taking place on Sunday, March 9th, 11:00 AM – 5:30 PM ET, this event will provide six (6) hours of COPE-accredited clinical continuing education to optometrists across the country and will be presented in a synchronous, virtual Zoom webinar format. In accordance with current COPE/ARBO guidelines there are no testing requirements for synchronous virtual formatted courses to count as COPE approved CE credits.
Expand your knowledge and learn new treatment methods for eye conditions related to metabolic diseases, opioids, ocular surface disease and sexually transmitted infections. Information gained through these sessions will empower you with cutting-edge treatment options for a variety of conditions that extend beyond traditional eye care.
Ocular Treatments: A Cutting-Edge Approach is open to all optometrists nationwide, including PECAA Max members, HEA Advantage members and non-members — PECAA Propel members are also invited to join us. We look forward to welcoming you to this event.
Our Speakers
Event Agenda
Ocular Treatments: A Cutting-Edge Approach (3/9/2025)
6 Hours CE Credit — COPE Event ID: COPE Pending
To view the agenda in your Time Zone, click the button below.
All times shown below are Eastern (ET).
10:30 AM — Webinar Opens
11:00 – 11:10 AM — Webinar Begins: Announcements And Introductions
Please Note: All participants must be online at this time in order to receive full credit.
11:10 AM – 12:50 PM — Metabolic Diseases: Updates And Systemic Interventions
Speaker: Tracy Offerdahl, PharmD, BPharm, RPh, FAAO
CE Hours: 2 — COPE Course ID: 90011-PH
Description: This course reviews common metabolic diseases, including diabetes mellitus (Type 2), hyperlipidemia, and thyroid disease. This course will describe recent updates in treatment guidelines and side effects associated with medications used in these diseases, as well as a discussion about the impact of epigenetics. Patient case anecdotes will be integrated into the presentation, where differential diagnosis and work-up will be discussed.
12:50 – 1:00 PM — Q&A
1:00 – 1:10 PM — Break
1:10 – 2:50 PM — Treatment Of Pain: Opioid Choices And Issues For Patient And Practitioner
Speaker: Tracy Offerdahl, PharmD, BPharm, RPh, FAAO
CE Hours: 2 — COPE Course ID: 90864-PH
Description: This is an oral pharmacology course that describes the appropriate use of opioid medications, with an emphasis on pain management within the scope of Optometry and general pain management. Case anecdotes will include management of ocular pain, with specific emphasis on oral/systemic medications. Opioid medications will be evaluated in terms of risk versus benefit, with an emphasis on appropriate use of pain medications, evaluation of potential addiction, and a description on how to protect both patient and practitioner.
2:50 – 3:00 PM — Q&A
3:00 – 3:15 PM — Break
3:15 – 4:05 PM — You, Me, And OSD
Speaker: Thomas Kislan, OD
CE Hours: 1 — COPE Course ID: 93072-TD
Description: This course will cover basic ocular surface disease diagnosis, treatment, and management following a patient from the first phone call to the office through their follow up visits. Discussion of OTCs, nutraceuticals, prescription and mechanical treatments will be in the forefront.
4:05 – 4:15 PM — Q&A
4:20 – 5:10 PM — STIs And The Eye: Protecting The Unprotected
Speaker: Caroline Donato, OD, FAAO
CE Hours: 1 — COPE Course ID: 92413-SD
Description: This course details the common systemic and ocular presentations of sexually transmitted diseases that optometrists may encounter. The detection, treatment, and management of these conditions will be discussed, as well as how to communicate with patients regarding their diagnosis. Cases will be presented.
5:10 – 5:20 PM — Q&A
5:20 – 5:30 PM — Conclusion And Adjournment
Thank You To Our Supporting Vendor Partners!
This event is supported by the following PECAA vendor partners.
We sincerely thank them for their support!
CooperVision
Johnson & Johnson